## ACT: Enact Holdings, Inc. - XLF: Financial Services

### Executive Summary

No thesis match: MRS_20 3.3% below STRENGTH zone (4.0-10.0%); PEG unavailable fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($38.30)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 2
- **Sentiment:** Bullish (Bullish: 1, Bearish: 0)

**1. Enact Holdings stock hits all-time high at 39.48 USD**
- Source: Investing.com | 20251212T150939 | Bullish | Relevance: 100%
- Enact Holdings stock reached an all-time high of $39.48, marking a robust performance with a 16.22% increase over the past year and a 24.23% year-to-date return. The company, trading at a P/E ratio of 9 and offering a 2.14% dividend yield, is considered undervalued by InvestingPro, which also notes management's aggressive share buybacks and a "GREAT" financial health score. This milestone follows strong Q3 2025 earnings, where EPS and revenue surpassed analyst expectations, reflecting investor confidence and strategic growth.

**2. Enact Holdings, Inc. (ACT) Matches Q3 Earnings Estimates**
- Source: MSN | 20251210T220958 | Neutral | Relevance: 100%
- The article reports that Enact Holdings, Inc. (ACT) has matched its Q3 earnings estimates. Further details about the financial performance for the third quarter are expected to be available, confirming that the company met analyst expectations.

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 1 ($0.00M) |
| Sells | 5 ($102.59M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 13.0% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 7 / 2 |

**Top Holders:**
- Blackrock Inc.: 3.2% (+1.0%)
- Vanguard Group Inc: 2.2% (-2.0%)
- Dimensional Fund Adv: 1.9% (+7.1%)
- First Trust Advisors: 1.0% (+87.9%)
- Qube Research & Tech: 1.0% (+289.4%)

### Key Risks

1. Heavy insider selling: $103M sold (5 transactions in 90 days).
2. High short interest (16.2%, 12.6 days to cover): squeeze risk or crowded bearish bet.
3. Market regime shift could impact momentum names disproportionately.

### Catalysts

- Momentum building: MRS_20 improving +5.8% over 5 days suggests accumulation.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

Forward P/E 8.6x stretched relative to 3% growth. Quality metrics strong (margin 54%). Balance sheet: strong liquidity (6612078000.0x), low leverage (D/E 0.29). Insider selling cluster ($102.6M in 90 days), potential headwind. Institutional flow bullish (7 buying vs 2 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $5.9B |
| Beta | 0.52 |
| 52W Range | $30.79 - $39.76 |
| Short Interest | 16.2% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | N/A |
| Forward P/E | 8.6 |
| Current P/E | 8.9 |
| YoY Growth | 3.5% |
| EPS Direction | STABLE |

### Technicals

MRS_20 strengthening from -2.5% to 3.3% (+5.8% in 5 days), confirming momentum buildup. Below STRENGTH zone by 0.7pp (needs >4.0% for momentum thesis). MRS_5 at 4.0% confirms short-term momentum alignment. AM_20 at 3.7% shows strong absolute momentum above own 20MA. Full SMA alignment bullish (above 20/50/200 SMAs). OFD pattern: +MLN (Support).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 3.31% (CS: 64) | Neutral |
| RSI_14 | 66.8 | Neutral |
| MACD Histogram | 0.06 | Bullish |
| vs SMA20 | 1.036x | Above |
| vs SMA50 | 1.073x | Above |
| vs SMA200 | 1.096x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $39.74
- **Stop Loss:** $38.30 (3.6% risk)
- **Target:** $41.18 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 833
- **Position Value:** $33,103.42
- **Portfolio %:** 33.10%
- **Risk Dollars:** $1,200.00
- **Risk Per Trade:** 1.20%
- **Modifiers:** L1 100% | L2 120% | Combined 1.20x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | MOMENTUM (Zone F) | 1.20x |

*NORMAL regime with moderate risk appetite ahead of Fed decision. VIX remains calm at 15.74 while breadth shows modest participation at 54%, suggesting selective positioning. FOMC meeting in 4 days creates near-term uncertainty but no systemic stress evident.*

### Earnings

**Next:** 2026-02-04 (Est: $1.10)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $1.11 | $1.12 | +0.9% |
| 2025Q2 | $1.11 | $1.15 | +3.9% |
| 2025Q1 | $1.09 | $1.10 | +0.9% |
| 2024Q4 | $1.08 | $1.09 | +0.7% |

---
*RULE-based L3 | 2026-01-06 16:36 | MRS_20*